
<table style="text-align:center"><caption><strong>Poisson Models of Orphan Drug Market Authorizations (Not adjusted for Error Structure)</strong></caption>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"></td><td colspan="6"><em>Dependent variable:</em></td></tr>
<tr><td></td><td colspan="6" style="border-bottom: 1px solid black"></td></tr>
<tr><td style="text-align:left"></td><td colspan="6">Annual Number of Market Authorized Orphan Drugs</td></tr>
<tr><td style="text-align:left"></td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td><td>(6)</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD)</td><td></td><td></td><td>-0.001</td><td>-0.0001</td><td>-0.001</td><td>0.0001</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td>(0.006)</td><td>(0.044)</td><td>(0.007)</td><td>(0.044)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">US</td><td>1.400<sup>***</sup></td><td>0.610<sup>***</sup></td><td>0.610<sup>***</sup></td><td>0.620</td><td>0.610<sup>***</sup></td><td>0.620</td></tr>
<tr><td style="text-align:left"></td><td>(0.081)</td><td>(0.190)</td><td>(0.190)</td><td>(0.690)</td><td>(0.190)</td><td>(0.690)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004</td><td>0.110<sup>***</sup></td><td>0.054<sup>***</sup></td><td>0.055<sup>***</sup></td><td>0.054</td><td>0.055<sup>***</sup></td><td>0.054</td></tr>
<tr><td style="text-align:left"></td><td>(0.007)</td><td>(0.014)</td><td>(0.016)</td><td>(0.055)</td><td>(0.016)</td><td>(0.056)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual GDP Growth Rate</td><td></td><td></td><td></td><td></td><td>-0.034</td><td>-0.036</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td>(1.300)</td><td>(1.300)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Years After 2004:US</td><td></td><td>0.071<sup>***</sup></td><td>0.073<sup>***</sup></td><td>0.074</td><td>0.073<sup>***</sup></td><td>0.074</td></tr>
<tr><td style="text-align:left"></td><td></td><td>(0.016)</td><td>(0.021)</td><td>(0.060)</td><td>(0.021)</td><td>(0.060)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Annual Domestic R&D Spending (Billions USD):US</td><td></td><td></td><td></td><td>-0.001</td><td></td><td>-0.001</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td>(0.045)</td><td></td><td>(0.045)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td style="text-align:left">Intercept</td><td>1.300<sup>***</sup></td><td>1.900<sup>***</sup></td><td>1.900<sup>***</sup></td><td>1.900<sup>***</sup></td><td>1.900<sup>***</sup></td><td>1.900<sup>***</sup></td></tr>
<tr><td style="text-align:left"></td><td>(0.110)</td><td>(0.160)</td><td>(0.190)</td><td>(0.670)</td><td>(0.190)</td><td>(0.670)</td></tr>
<tr><td style="text-align:left"></td><td></td><td></td><td></td><td></td><td></td><td></td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left">Observations</td><td>35</td><td>35</td><td>35</td><td>35</td><td>35</td><td>35</td></tr>
<tr><td style="text-align:left">Log Likelihood</td><td>-125.000</td><td>-116.000</td><td>-116.000</td><td>-116.000</td><td>-116.000</td><td>-116.000</td></tr>
<tr><td style="text-align:left">Akaike Inf. Crit.</td><td>257.000</td><td>239.000</td><td>241.000</td><td>243.000</td><td>243.000</td><td>245.000</td></tr>
<tr><td colspan="7" style="border-bottom: 1px solid black"></td></tr><tr><td style="text-align:left"><em>Note:</em></td><td colspan="6" style="text-align:right"><sup>*</sup>p<0.1; <sup>**</sup>p<0.05; <sup>***</sup>p<0.01</td></tr>
</table>
